Sorrento Therapeutics, Inc. (47) | Intellectual Property (5)

Browse by Subcategory

License Agreements (5)

Recent Contracts

Exclusive License Agreement, dated as of March 4, 2021, by and between Sorrento Therapeutics, Inc. and the Icahn School of Medicine at Mount Sinai (Filed With SEC on May 5, 2021)
License Agreement, dated as of October 12, 2020, by and between Sorrento Therapeutics, Inc. and Personalized Stem Cells (Filed With SEC on February 19, 2021)
License Agreement, dated as of July 13, 2020, by and between Sorrento Therapeutics, Inc. and ACEA Therapeutics, Inc (Filed With SEC on November 9, 2020)
Exclusive License Agreement, dated as of July 23, 2020, by and between Sorrento Therapeutics, Inc. and The Trustees of Columbia University in the City of New York (Filed With SEC on November 9, 2020)
Patent and Know-How License Agreement, dated as of September 8, 2020, by and between Sorrento Therapeutics, Inc. and Mayo Foundation for Medical Education and Research (Filed With SEC on November 9, 2020)